Royal London Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.4M Sell
166,288
-90
-0.1% -$18.7K 0.07% 217
2026
Q1
$35.2M Buy
166,378
+1,722
+1% +$371K 0.07% 233
2025
Q4
$33.8M Sell
164,656
-3,779
-2% -$711K 0.07% 229
2025
Q3
$26.4M Buy
168,435
+63,051
+60% +$9.74M 0.06% 270
2025
Q2
$17.7M Sell
105,384
-470
-0.4% -$69.8K 0.04% 340
2025
Q1
$14.5M Buy
105,854
+5,539
+6% +$706K 0.03% 374
2024
Q4
$11.9M Buy
100,315
+58
+0.1% +$6.77K 0.03% 395
2024
Q3
$11M Buy
100,257
+2,582
+3% +$270K 0.03% 407
2024
Q2
$9.55M Buy
97,675
+545
+0.6% +$55.5K 0.02% 409
2024
Q1
$10.9M Sell
97,130
-2,779
-3% -$300K 0.03% 383
2023
Q4
$10.1M Buy
99,909
+1,890
+2% +$188K 0.03% 386
2023
Q3
$8.51M Buy
98,019
+3,088
+3% +$279K 0.03% 403
2023
Q2
$8.98M Buy
94,931
+4,108
+5% +$347K 0.03% 382
2023
Q1
$6.86M Sell
90,823
-736
-0.8% -$55.5K 0.03% 393
2022
Q4
$7.04M Sell
91,559
-7,816
-8% -$594K 0.03% 388
2022
Q3
$6.63M Sell
99,375
-506
-0.5% -$32.1K 0.03% 371
2022
Q2
$5.22M Hold
99,881
0.02% 436
2022
Q1
$5.66M Hold
99,881
0.02% 465
2021
Q4
$5.14M Sell
99,881
-6,508
-6% -$319K 0.02% 481
2021
Q3
$5.26M Hold
106,389
0.02% 481
2021
Q2
$6.07M Hold
106,389
0.02% 467
2021
Q1
$6.46M Buy
106,389
+87
+0.1% +$4.8K 0.03% 413
2020
Q4
$5.69M Sell
106,302
-198
-0.2% -$10.3K 0.03% 407
2020
Q3
$4.99M Hold
106,500
0.03% 400
2020
Q2
$5.53M Sell
106,500
-6,643
-6% -$342K 0.04% 359
2020
Q1
$5.49M Hold
113,143
0.04% 337
2019
Q4
$5.75M Buy
113,143
+781
+0.7% +$40.3K 0.04% 378
2019
Q3
$5.3M Sell
112,362
-5,169
-4% -$236K 0.04% 392
2019
Q2
$5.53M Sell
117,531
-3,308
-3% -$153K 0.05% 330
2019
Q1
$5.82M Sell
120,839
-13,970
-10% -$700K 0.05% 377
2018
Q4
$6.01M Buy
134,809
+8,482
+7% +$442K 0.05% 357
2018
Q3
$6.82M Sell
126,327
-7,425
-6% -$380K 0.07% 274
2018
Q2
$6.53M Buy
+133,752
New +$7.58M 0.07% 306
2016
Q2
$8.65M Buy
110,850
+29,850
+37% +$2.38M 0.14% 157
2016
Q1
$6.67M Sell
81,000
-38,385
-32% -$3.12M 0.16% 135
2015
Q4
$10.8M Buy
119,385
+1,383
+1% +$117K 0.17% 135
2015
Q3
$9.06M Buy
+118,002
New +$9.86M 0.15% 153
2014
Q4
$8.68M Buy
106,079
+22,235
+27% +$1.76M 0.16% 139
2014
Q3
$6.34M Buy
83,844
+5,082
+6% +$370K 0.16% 144
2014
Q2
$5.54M Sell
78,762
-356
-0.4% -$24.2K 0.13% 182
2014
Q1
$5.14M Sell
79,118
-342
-0.4% -$23.8K 0.12% 191
2013
Q4
$5.51M Buy
79,460
+959
+1% +$58.6K 0.14% 170
2013
Q3
$4.32M Buy
78,501
+982
+1% +$49.9K 0.12% 197
2013
Q2
$3.7M Buy
+77,519
New +$3.54M 0.11% 213

Other funds holding CAH

Royal London Asset Management's CAH Position: Q2 2026 in Review

Royal London Asset Management reduced its Cardinal Health (CAH) stake by 0.05% in Q2 2026, selling an estimated $18.7K and leaving 166,288 shares worth $39.4M. The position accounts for 0.07% of the portfolio, ranked #217.

Royal London Asset Management first reported a position in CAH in Q2 2013 and has held it in 44 quarters since. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Royal London Asset Management held 166,288 shares of Cardinal Health worth $39.4M as of Q2 2026.
  • Royal London Asset Management sold 90 Cardinal Health shares in Q2 2026, an estimated $18.7K.
  • Cardinal Health made up 0.07% of Royal London Asset Management's portfolio in Q2 2026, its #217 holding.
  • Royal London Asset Management first reported a position in Cardinal Health in Q2 2013 and has held it in 44 quarters since.
  • 1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Royal London Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.